Gentris | A CGI Company is a biotechnology startup founded in 2001 and based in the United States. As a subsidiary of Cancer Genetics, Inc., Gentris is a global provider of pharmacogenomic testing and biorepository services. The company works with pharmaceutical companies and clinical research organizations to integrate pharmacogenomics into drug development programs, aiming to bring safer and more effective compounds to the market at an accelerated pace.
With a focus on better patient population characterization, Gentris aims to reduce drug failure rates by enabling drug companies to tailor patients’ exposure to drugs based on their genomic drug-response profile. This personalized approach ensures that the most suitable drugs reach the right patients at the appropriate dosages, maximizing the benefits of their pharmacogenomic profile.
The company's last notable investment was a $5.00M Venture Round investment on 27 April 2005, with Mitsui Global Investment participating as the investor.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $5.00M | 1 |
|
27 Apr 2005 |
| Angel Round | Unknown | 1 |
|
01 Dec 2003 |
No recent news or press coverage available for Gentris | A CGI Company.
We care about your data, and we'd love to use cookies make your experience better.
